Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:isotretinoin
|
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:brand |
gptkb:isotretinoin
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to isotretinoin |
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Absorica
|
| gptkbp:manufacturer |
gptkb:Sun_Pharmaceutical_Industries
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:requires |
gptkb:iPLEDGE_program_enrollment
|
| gptkbp:riskFactor |
teratogenicity
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:depression
elevated liver enzymes cheilitis hyperlipidemia dry skin |
| gptkbp:usedFor |
severe recalcitrant nodular acne
|
| gptkbp:bfsParent |
gptkb:Sun_Pharma
|
| gptkbp:bfsLayer |
6
|